| PUBCHEM ID |
73425415
|
| UNII |
2117GXC75C
|
| Preferred Term |
ARABOFLAVIN TETRAACETATE, D-
|
| CAS |
5978-88-1
|
| INCHIKEY |
VKVDYPHLGLIXAG-SJBKTWHCSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(OC[C@H]([C@H]([C@@H](CN(c(cc(C)c(C)c1)c1N=C1C(N2)=O)C1=NC2=O)OC(C)=O)OC(C)=O)OC(C)=O)=O
|
| Total Surface Area |
399,04
|
| Relative PSA |
0,39161
|
| TPSA |
179,33
|
| cLogS |
-4,067
|
| MW |
544,515
|
| cLogP |
-0,1279
|
| H-Acceptors |
14
|
| H-Donors |
1
|
| Ro5 violations |
2
|
| Druglikeness |
5,963
|
| DrugScore |
0,585624758610103
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,9507
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,3688
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3945
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3113
|
| Carcinogenicity (Three-class) |
Non-required
|
